Literature DB >> 16630327

Combination pharmacotherapy for severe neonatal pulmonary hypertension.

Peter M Filan1, Peter N McDougall, Lara S Shekerdemian.   

Abstract

Pulmonary hypertension can complicate the early clinical course in newborn infants with congenital diaphragmatic hernia. We report the successful use of combination therapy with enteral sildenafil and intravenous prostaglandin E1 in a preterm infant with severe pulmonary hypertension and right heart failure early after congenital diaphragmatic hernia repair.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630327     DOI: 10.1111/j.1440-1754.2006.00835.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use.

Authors:  Maurizio Radicioni; Alessia Bruni; Piergiorgio Camerini
Journal:  Eur J Pediatr       Date:  2011-03-08       Impact factor: 3.183

Review 2.  Use of Prostaglandin E1 in the Management of Congenital Diaphragmatic Hernia-A Review.

Authors:  Srirupa Hari Gopal; Neil Patel; Caraciolo J Fernandes
Journal:  Front Pediatr       Date:  2022-07-01       Impact factor: 3.569

Review 3.  Sildenafil for the treatment of pulmonary hypertension in pediatric patients.

Authors:  Alice J Huddleston; Chad A Knoderer; Jennifer L Morris; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

Review 4.  Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.

Authors:  Satyan Lakshminrusimha; Bobby Mathew; Corinne L Leach
Journal:  Semin Perinatol       Date:  2016-01-14       Impact factor: 3.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.